home / stock / lumo / lumo articles

LUMO Articles, Lumos Pharma Inc.

Stock Information
Company Name: Lumos Pharma Inc.
Stock Symbol: LUMO
Market: NASDAQ
Website: lumos-pharma.com
Menu
LUMO LUMO Quote LUMO Short LUMO News LUMO Articles LUMO Message Board
Get LUMO Alerts

News, Short Squeeze, Breakout and More Instantly...
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 | Benzinga

AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeu...
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 | Benzinga

AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic ca...

Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024 | Benzinga

AUSTIN, Texas, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic can...

Lumos Pharma to Participate in Oppenheimer's 34th Annual Healthcare Life Sciences Conference | Benzinga

AUSTIN, Texas, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic can...
Lumos Pharma Promotes Pisit "Duke" Pitukcheewanont, MD to Chief Medical Officer | Benzinga

AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutic...

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency | Benzinga

AUSTIN, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic can...

Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November | Benzinga

AUSTIN, Texas, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therape...
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. GAN Limited (NASDAQ: GAN) sh...

Why Is Biomarin & BridgeBio Pharma Rival Lumos Pharma Stock Trading Higher Today? | Benzinga

Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2 OraGrowtH212 P...

Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today...
Next 10